WA42293 PRM-151-303: A PHASE III RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF PRM-151 IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS

Administered By

Awarded By

Contributors

Start/End

  • January 12, 2022 - December 31, 2025